tbuckley/cabot-search huggingface dataset:
Outcomes of Second-Line Tyrosine Kinase Inhibitors after First-Line Imatinib in Chronic Myelogenous Leukemia: A Retrospective Cohort Study
Authors: Muaz Alsabbagh Alchirazi, Hadil Zureigat, Ahmed N Mohamed, Aastha Dhakal, Ali Mushtaq, Naveen Rehman, Bryan Berube, Sneha Govande, Emily C. Zabor, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Anjali S. Advani, Hetty E. Carraway, Matt Kalaycio, Sudipto Mukherjee, Moaath K. Mustafa Ali
Journal: Blood (2024)
Transcription Factor Gata2 Regulates the Myeloid-Lymphoid Fate Decision in Multipotent Progenitors
Authors: Yuya Tanaka, Hiroki Kato, Sayaka Sano, Daigo Michimata, Kazuki Sakurai, Kazuki Hashimoto, Naoya Morota, Koichi Onodera, Shunsuke Hatta, Noriko Fukuhara, Yasushi Onishi, Tohru Fujiwara, Hideo Harigae
Journal: Blood (2024)
Fibrinogen and D-Dimer Predict Venous Thromboembolism (VTE) in a Prospective Observational Cohort of Metastatic Breast Cancer Patients
Authors: Cristina Verzeroli, Laura Russo, Sara Gamba, Carmen J Tartari, Silvia Bolognini, Chiara Ticozzi, Patricia Gomez-Rosas, Francesca Schieppati, Roberta Sarmiento, Giovanna Masci, Carlo Tondini, Fausto Petrelli, Francesco Giuliani, Andrea D'Alessio, Filippo De Braud, Armando Santoro, Giampietro Gasparini, Roberto Labianca, Luca Barcella, Marina Marchetti, Anna Falanga
Journal: Blood (2024)
ADAMTS13 Activity Measurement Using a Chemiluminescence-Based Technique. Prospective Multicenter Comparative Study of the Spanish Apheresis Group (GEA)- Spanish Society of Hematology and Hemotherapy (SEHH)
Authors: Maria Cristina Pascual Izquierdo, Jorge Martínez Nieto, Maribel Diaz-Ricart, Marta Fernández Docampo, Ines Gomez Segui, Manuel Fernanadez-Villalobos, Rafel López del Amo, Patricia Martinho, Silvia Escribano-Serrat, Julia Martinez-Sanchez, ANA Belen MORENO Castaño, Toni Moscardo, Eva Mingot Castellano, Amanda Lopez Picado, Ramon Salinas Argente, Julio Del Rio Garma, Teresa Fidalgo
Journal: Blood (2024)
Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS)
Authors: Aristoteles Giagounidis, Monteserrat Arnan, Lynette C.Y. Chee, Thomas Cluzeau, Maria Diez-Campelo, Devendra Hiwase, David M Ross, Mikkael A. Sekeres, Shuhying Tan, David Valcarcel, Rena Buckstein, Bhavna Patel-Shah, Ming Yang, Ying Jiang, Jiani Yin, Suresh Bobba, Montagu Hankin, Chris Materna, Christine Graham, Sanjay Thamake, Christopher Rovaldi, Dena Grayson, Jen L. Salstrom
Journal: Blood (2024)
The Impact of Body Mass Index (BMI) in Patients with Aplastic Anemia Receiving Weight-Adjusted Horse Anti-Thymocyte Globulin (hATG) on Outcome, Response and Relapse Rate
Authors: Jeanette Walter, Benjamin Rolles, Yannic Schumacher, Frauke Theis, Leo Hansmann, Markus P. Radsak, Michael Heuser, Julia-Annabell Georgi, Jörg Chromik, Beatrice Drexler, Jörg Schubert, Kim Kricheldorf, Jens Panse, Thomas Stiehl, Tim H. H. Brummendorf, Bhavisha A. Patel, Neal S. Young, Emma M. Groarke, Fabian Beier
Journal: Blood (2024)
Dynamic Shifts in Inflammation and Fibrotic Remodeling in Post-HSCT Bronchiolitis Obliterans: A Spatial Transcriptomics Study
Authors: Akira Yamamoto, Nobuharu Fujii, Keisuke Seike, Seiichiro Sugimoto, Yusuke Naoi, Yui Kambara, Kanako Fujiwara, Toshiki Terao, Tadashi Oyama, Mari Kunihiro, Takumi Kondo, Hiroki Kobayashi, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Keiko Fujii, Shinichi Toyooka, Yoshinobu Maeda
Journal: Blood (2024)
Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study
Authors: Saki Ogawa, Kotaro Shide, Masami Takeuchi, Kosei Matsue, Takuro Kameda, Masato Yasumi, Takahiro Karasuno, Taizo Shimomura, Hitoshi Suzushima, Kiyoshi Yamashita, Noriaki Kawano, Osamu Imataki, Norimitsu Kadowaki, Akihito Yonezawa, Eiichi Otsuka, Yoshio Saburi, Yuki Tahira, Ayako Kamiunten, Keiichi Akizuki, Masayoshi Karasawa, Ryoma Ikeda, Kengo Matsumoto, Ayuka Kuroki, Koshiro Nagamine, Yoko Kubuki, Kazuya Shimoda
Journal: Blood (2024)
Immune Crosstalk Profiling of Non-Hodgkin Lymphoma (NHL) Tumor Immune Microenvironment Identifies Two Clusters Based on T Cell Exhaustion, Correlating with Different Clinical Outcomes
Authors: Daniel Medina, Laura Palomo, Víctor Navarro, Cristina García, Juan Camilo Nieto, Júlia Carabia, Carlota Pagès Geli, Pamela Acha, Gemma Pujadas, Carlos Palacio, Laura Gallur, Josep Castellvi, Pau Abrisqueta, Francesc Bosch, Marta Crespo
Journal: Blood (2024)
The Hyperbolic NAMPT Inhibitor RPT1G Synergizes with BCL-2 Family Inhibitors and Helps Overcome Venetoclax Resistance in Acute Myeloid Leukemia Cells
Authors: Gregory Crimmins, Min Wu, Francis Roushar, Claudia F. Ramos Aguilar, Mehdi Gharghabi, Banumathi Cole, Rosa Lapalombella, Dennise A. De Jesús-Díaz
Journal: Blood (2024)
Safety and Tolerability of BCMA-Directed mRNA CAR T-Cell Therapy in Multiple Myeloma and Autoimmune Disease
Authors: Milos D Miljkovic, Adam S. Asch, Gregory Orloff, Ralph Boccia, Jesús G Berdeja, Fevzi Altuntas, Stefan O. Ciurea, James F Howard, Tuan Vu, Bennett Myers, Nizar Chahin, Tahseen Mozaffar, Christopher M Jewell, Metin Kurtoglu
Journal: Blood (2024)
Characteristics and Outcomes of Patients with Double Refractory (DR) or Double Exposed (DE) CLL
Authors: James T. Yoon, Yinglu Zhou, Svitlana Tyekucheva, Mariia Mikhaleva, Stacey M. Fernandes, Philippe Armand, Amy C. Bessnow, Jennifer L. Crombie, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Reid W. Merryman, Oreofe O. Odejide, Erin M. Parry, David A. Qualls, Christine E. Ryan, Aswin Sekar, Jacob D. Soumerai, Jon E. Arnason, Matthew S. Davids, Jennifer R. Brown, Inhye E. Ahn
Journal: Blood (2024)
Polatuzumab-Vedotin Plus Bendamustine and Rituximab for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis
Authors: Andres Bravo-Gonzalez, Maria Paula Alviar-Ortiz, Elsa Vasquez-Trespalacios, Georgios Pongas
Journal: Blood (2024)
Clinical Outcomes of Patients with High-Risk Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 ELARA 4-Year Update
Authors: Catherine Thieblemont, Martin Dreyling, Michael J. Dickinson, Joaquín Martínez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio C. Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A. Riedell, Phoebe Joy Ho, Jose Antonio Pérez-Simón, Andy Chen, Loretta Nastoupil, Bastian von Tresckow, Andrés José María Ferreri, Takanori Teshima, Piers E.M. Patten, Joseph P. McGuirk, Fritz Offner, Andreas Viardot, Pier Luigi Zinzani, Ram Malladi, Aiesha Zia, Rakesh Awasthi, Davide Germano, Roberto Javier Ramos, Pei Hsu, Stephen J. Schuster, Nathan H. Fowler
Journal: Blood (2024)
CD22-Directed CAR T-Cell Therapy Achieves Complete Remission in CD19-Directed CAR T-Cell Refractory Follicular and Mantle Cell Lymphoma
Authors: Anne Marijn Kramer, Hrishikesh Srinagesh, Yi-Jiun Su, Mark P. Hamilton, Kendall Levine, Eleonora Migliore, Kimi DeNoble, Annie K. Brown, Kristen Cunanan, Neha Agarwal, Claire Lohman, Sharon Mavroukakis, Sushma Bharadwaj, Sally Arai, Laura Johnston, Robert Lowsky, Everett H. Meyer, Robert S. Negrin, Andrew R. Rezvani, Judith Shizuru, Lekha Mikkilineni, Hitomi Hosoya, Parveen Shiraz, Surbhi Sidana, Wen-Kai Weng, Vanessa E. Kennedy, Melody Smith, Saurabh Dahiya, Kara L. Davis, Sneha Ramakrishna, Liora Michal Schultz, Ramya Tunuguntla, Steven A. Feldman, Lori Muffly, Crystal L. Mackall, David B. Miklos, Matthew J. Frank
Journal: Blood (2024)
Cytokine Modulation Correlates Strongly with Symptom Improvement in Patients with Myelofibrosis Treated with Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor
Authors: Lindsay A.M. Rein, Firas El Chaer, Junichiro Yuda, Kazuya Shimoda, Raajit Rampal, Joseph M. Scandura, Akiyoshi Takami, James McCloskey, Michiko Ichii, Shuichi Shirane, Alessandra Iurlo, Prithviraj Bose, Alessandro Lucchesi, Giulia Benevolo, Idoroenyi Amanam, Pankit Vachhani, Srinivas K Tantravahi, Marcello Rotta, Yasushi Onishi, Jean-Jacques Kiladjian, Ciro Rinaldi, Nikki Granacher, Terrence Bradley, Anand Ashwin Patel, Michael Loschi, Samah Alimam, Stanley Cheung, Vincent Ribrag, Sujan Kabir, Masataka Seki, Karen Ansaldo, Guia Guffanti, Jinny Lee, Steven L. Warner, Jason M. Foulks, Ruben Mesa
Journal: Blood (2024)
Trials in Progress: Decoy-Resistant Interleukin-18 (DR-18) for Relapse or Pre-Emptive Treatment of Measurable Residual Disease after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome (DR. DREAM), a Phase I Trial
Authors: Elizabeth Krakow, Laura Connelly-Smith, Catherine J. Lee, Dow Dunbar, Jeremy Barton, Beatrice P. McQueen, Geoffrey R. Hill, Jacob S. Appelbaum
Journal: Blood (2024)
A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: Swetha Kambhampati, Avyakta Kallam, Azra Borogovac, Lu Chen, Sandrine Puverel, Jennifer Johnson, Ivana Melgar, John H. Baird, Alexey Danilov, James Godfrey, Niloufer Khan, Matthew Mei, Tycel J. J. Phillips, Tanya Siddiqi, Geoffrey Shouse, Jasmine Zain, Larry W. Kwak, Steven T. Rosen, Stephen J. Forman, Joo Y. Song, Alex F. Herrera, Elizabeth Budde
Journal: Blood (2024)
Efficacy and Tolerability of Trametinib in Adults with Histiocytic Neoplasms
Authors: Rodothea Amerikanou, Tahla Munir, Kristian Bowles, Christopher McNamara, Nikesh Dhiraj Chavda, Azeem Ahmed, Jagdish Adiyodi, Alasdair Coles, Philippa Kelsey, Jeffery Smith, Richard Adams, Hayder KA Hussein, Rui Zhao, Amelia Taylor, Trung Nguyen, Satyen Gohil, Matthew Collin
Journal: Blood (2024)
Telomere Length Associations with Characteristics and Outcome in Patients Treated with Venetoclax-Based First-Line Combinations in the GAIA/CLL13 Study
Authors: Billy Jebaraj, Eugen Tausch, Deyan Y. Yosifov, Christof Schneider, Moritz Fürstenau, Can Zhang, Sandra Robrecht, Caspar da Cunha-Bang, Mark-David Levin, Philipp Bernhard Staber, Tamar Tadmor, Patrick Thornton, Michael Gregor, Anna Maria Fink, Kirsten Fischer, Matthias Ritgen, Michael Hallek, Arnon P. Kater, Carsten Utoft Niemann, Barbara F. Eichhorst, Stephan Stilgenbauer
Journal: Blood (2024)
QRISK3: A New Marker for Thrombotic Events in Essential Thrombocythemia and Polycythemia Vera at Diagnosis and during Follow up
Authors: Andrea Duminuco, Sukhraj Singh Virdee, Raj Vaghela, Kyaw Htin Thaw, Claire Woodley, Susan Asirvatham, Priya Sriskandarajah, Hugues de Lavallade, Deepti H. Radia, Natalia Curto-Garcia, Jennifer O'Sullivan, Andrew Doyle, Shahram Kordasti, Giuseppe Alberto Palumbo, Claire Harrison, Patrick Harrington
Journal: Blood (2024)
Standardization Protocol to Mitigate Progression of Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) in Elderly Patients Treated with CD28 Co-Stimulatory Anti-CD19 CAR-T Cells - a Pilot Study
Authors: Gil Fridberg, Odelia Amit, Mohamad Ganayem, Felix Bukstein, Chava Perry, Irit Avivi Mazza, Ronit Gold, Ron Ram
Journal: Blood (2024)
Novel MET Inhibitors Provide a Therapeutic Opportunity for AML By Overcoming the Protective Action of the Bone Marrow Niche
Authors: Maura Lima Pereira Bueno, Charles Ayemoba, Anna M Di Staulo, Sen Zhang, Fernanda Soares Niemann, Nádia Ghinelli Amôr, Irene Santos, Adriana da Silva Santos Duarte, Audrey Bastos, Sara Teresinha Olalla Saad, Sandra Pinho, Fernanda Marconi Roversi
Journal: Blood (2024)
Role of Factor VIII in Angiogenesis, Vessel Stability and the Regulation of Extracellular Matrix Proteins
Authors: Cristina Olgasi, Alessia Cucci, Ivan Molineris, Simone Assanelli, Chiara Borsotti, Chiara Sgromo, Andrea Lauria, Mercello Manfredi, Salvatore Oliviero, Antonia Follenzi
Journal: Blood (2024)
Trial in Progress - Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma
Authors: Anne W Beaven, Susan M. Geyer, Jonathon B. Cohen, Tycel Phillips, Travis Dockter, Priyanka A. Pophali, Gita Thanarajasingam, Gina L. Mazza, Alvaro J Alencar, Shira N. Dinner, Eric D. Hsi, Meng Welliver, Daniel Nikcevich, Brad S. Kahl, Jonathan W. Friedberg, Nancy L. Bartlett, John P. Leonard
Journal: Blood (2024)
Novel Combination Regimen Brentuximab Vedotin-Bege Achieves Remarkable Efficacy in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
Authors: Xi Chen, Huilin Peng, Haifeng Yu, Cong Li, Tao Lei, Shuiyun Han, Shuailing Peng, Haiyan Yang
Journal: Blood (2024)
Practical Microenvironment Classification in Diffuse Large B-Cell Lymphoma Using Digital Pathology
Authors: Yuqing Wang, Shuo Wang, Hongmei Yi, Yue Wang, Haimin Xu, Shuang Tian, Yan Dong, Jing Zhao, Di Fu, Rongji Mu, Shuye Wang, Li Wang, Pengpeng Xu, Wei Li Zhao
Journal: Blood (2024)
Postpartum Hemorrhage in Women with Von Willebrand Disease after Enhanced Prophylactic Clotting Factor Suppletion: The Pregnancy and Inherited Bleeding Disorders Study (PRIDES)
Authors: Anne De Vaan, Jeroen Eikenboom, Marieke JHA Kruip, Marieke C Punt, Michiel Coppens, Laurens Nieuwenhuizen, Saskia EM Schols, Anja BU Mäkelburg, Floor CJI Moenen, Hans JJ Duvekot, Marjolein Peters, Annemieke JM Middeldorp, Kitty WM Bloemenkamp, Roger EG Schutgens, Titia AT Lely, Karin PM Van Galen
Journal: Blood (2024)
Prevalence and Trends of in-Hospital Outcomes Among Patients with Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: National Inpatient Sample 2016-2020
Authors: Jayalekshmi Jayakumar, Samridhi Sinha, Mrunanjali Gaddam, Rabia Iqbal, Swathi Kavuri, Ana Colon Ramos, Surbhi Singh, Sobha Atluri, Michelle Koifman, Kalimullah Quadri
Journal: Blood (2024)
Diffuse Large B-Cell Lymphoma and Hepatitis B Virus (HBV) Infection: An Emerging Health Disparity in Philadelphia
Authors: Ilana P. Goldberg, Douglas Russ, Roxanna Fouladi, Suraj Nyalakonda, Rebecca Masel, Safiyyah Bhatti, Colin Thomas, Jerald Gong, Thomas R. Klumpp, Alan Khoo, Pierluigi Porcu
Journal: Blood (2024)
Promotion of Engraftment by Triad of Pre-HCT Donor Lymphocyte Infusion, Distant Thymoglobulin and Approaching Cyclophosphamide in TCRαβ+-cell Depleted HCT for Patients with Thalassemia Major
Authors: Jianyun Liao, Chaoke Bu, Lan He, Jujian He, Weiwei Zhang, Yanfeng Zhou, Wenqian Shi, Yuqian Xia, Yuelin He, Chunfu Li
Journal: Blood (2024)
Impact of Ibrutinib on Quality of Life in Patients with Early-Stage, Asymptomatic Chronic Lymphocytic Leukemia: Results from the Phase III CLL12 Trial
Authors: Ellinor Goergen, Sandra Robrecht, Adam Giza, Can Zhang, Pascal Nieper, Florian Simon, Paula Cramer, Moritz Fürstenau, Othman Al-Sawaf, Nadine Kutsch, Anna Maria Fink, Ursula Vehling-Kaiser, Lothar Müller, Michael J. Eckart, Rudolf Schlag, Werner Freier, Tobias Gaska, Christina Balser, Marcel Reiser, Martina Beate Stauch, Clemens-Martin Wendtner, Eugen Tausch, Christof Schneider, Kirsten Fischer, Stephan Stilgenbauer, Barbara F. Eichhorst, Michael Hallek, Petra Langerbeins
Journal: Blood (2024)
Adenine Base Editing Improves Erythropoiesis in Diamond-Blackfan Anemia Syndrome Patient-Derived Induced Pluripotent Stem Cells
Authors: Shruthi Suryaprakash, Lei Han, Garret Manquen, Varun Katta, Damian Krzyzanowski, Jayaram Prasad, Nikitha Nimmagada, Kalin Mayberry, Nana Liu, Yan Ju, Yu Yao, Kelsey Ray, Marcin Wlodarski, Shengdar Q Tsai, Jonathan S Yen, Mitchell J Weiss, Senthil Velan Bhoopalan
Journal: Blood (2024)
Trial in Progress: Update on the TACL T2020-003 Randomized Phase 2 Trial to Improve Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL-2)
Authors: Etan Orgel, Sarah K. Tasian, Yueh-Yun Chi, Jemily Malvar, Christina M. Dieli-Conwright, Rubi Buxton, Mackenzie Frederick, Hannah Williams, Karen R Rabin, Susan R Rheingold, Robin Norris, Tamara P. Miller, Brent L. Wood, Ellynore Florendo, Ellen Chang, Lisa Hartman, Mallorie M. Heneghan, Michelle L. Hermiston, Joel Kaplan, Tamra Slone, Deepa Bhojwani, Alan S. Wayne, Steven D. Mittelman
Journal: Blood (2024)
Effectiveness of Nivolumab with ICE Protocol in Relapsed or Refractory Hodgkin Lymphoma: A Single-Center Experience from Riyadh, Saudi Arabia
Authors: Abdullah Alsakkaf, Alaa Eldein Yahia, Asim A Alharbi, Abdullah M. Alrajhi, Tahani Alhalouly, Bilal Albtoosh, Kamal Alzahrani, Mohammed S Alnoamani, Muhned Alhumaid, Hassan Alshehri, Nawal F Alshehry, Ibraheem H Motabi, Mohammed Marei, Imran K Tailor
Journal: Blood (2024)
A Phase 2 Prospective Study Evaluating Low-Dose Deferasirox in Patients with Low-Risk Myelodysplastic Syndrome Resistant or Relapsing after Erythropoietin Stimulating Agents (LODEFI)
Authors: Mathieu Meunier, Sylvain Thepot, Stanislas Nimubona, Mélanie Véloso, Thibaud Lefebvre, Karim Zoubida, Martine Ropert-Bouchet, Frederic Garban, Shanti Ame, Abdesssamia Gandoul, Claire Reynes, Celia Salanoubat, Sébastien Maury, Kamel Laribi, Pirayeh Eftekhari, Jacques Delaunay, Geoffroy Venton, Clemence Santana, Stephane Cheze, Sophie Dimicoli-Salazar, Mathieu Molimard, Valérie Rolland-Neyret, Sandra David-Tchouda, Sophie Park
Journal: Blood (2024)
Vididencel, a Leukemia-Derived Dendritic Cell Vaccine, Acts Synergistically with Azacitidine/Venetoclax Treatment in a Preclinical AML Model
Authors: Haoxiao Zuo, Calum Leitch, Jorn Kaspers, Mihaela Popa, Alex Karlsson-Parra, Erik Manting, Jeroen Rovers, Bjorn T. Gjertsen, Emmet McCormack, Satwinder Kaur Singh
Journal: Blood (2024)
Diagnosis and Prognosis of aGVHD By Metabolic Biomarkers after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Lei Wang, Ruigeng Yang, Shufeng Li, Jiancheng Fang, Xiaofei Luo, Wenli Sun, Chunfei Jiang, Meng Li, Yang Xue, Hongxing Liu
Journal: Blood (2024)
A Phase 2B, Open-Label Multicenter Study of Tebapivat (AG-946), a Potent Pyruvate Kinase Activator, in Patients with Anemia Due to Lower-Risk Myelodysplastic Syndromes
Authors: Amer M. Zeidan, Mikkael A. Sekeres, Hanny Al-Samkari, Hetty E. Carraway, Amy E. DeZern, Moshe Mittelman, Meredith Little, Vanessa Beynon, Xiaoshu Dai, Sal Sommakia, Jenny M. Despotovic, Parija Patel, Melissa Dibacco, Bruno Fattizzo, Eytan M. Stein, David Sallman, Austin G. Kulasekararaj, Uwe Platzbecker, Pierre Fenaux
Journal: Blood (2024)
Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial
Authors: Qi Liu, Yingying Shen, Lihong Shou, Yongming Xia, Sai Chen, Mei Zhou, Xiaohua Xu, Liqiang Wu, Jian-Zhi Zhao, Xiaohui Dong, Linglong Xu, Chunmeng Rong, Di Qiu, Wenbin Liu, Huijin Hu, Yuechao Zhao, Yun Zhang, Linjie Li, Yaping Xie, Xiaojun Xu, Huifang Jiang, Hui Zeng, Jiaping Fu, Li Huang, Xia Lin, Dan Chen, Yuhong Zhou, Baodong Ye, Yiping Shen, Dijiong Wu
Journal: Blood (2024)
Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma
Authors: Kunhwa Kim, Dai Chihara, Luis E. Fayad, Sattva S. Neelapu, Sairah Ahmed, Frederick Hagemeister, Chijioke Nze, Swaminathan P Iyer, Preetesh Jain, Michael Wang, Paolo Strati, Fateeha Furqan, Ayushi Chauhan, Michael R. Green, Christopher R. Flowers, Jason R. Westin
Journal: Blood (2024)
Activating STAT3 Mutations Drive CD38 Expression in T-Large Granular Lymphocytic Leukemia
Authors: Giulia Calabretto, Elena Buson, Zachary Hutchins, Colleen Isabelle, Sydnee Scozzafava, Valentina Trimarco, Barbara Mariotti, Rachel Burzinski, Amy Boles, Elisa Rampazzo, Antonella Teramo, Sabrina Manni, Monica Facco, Gregorio Barilà, Flavia Bazzoni, Gianpietro Semenzato, Livio Trentin, Jonathan E. Brammer, Renato Zambello, Anjali Mishra
Journal: Blood (2024)
Haploidentical Peripheral Blood Stem Cell Transplantation Improves the Survival of Older Patients with Myeloid Malignancies Under Low-Dose Antithymocyte Globin (ATG)/Post-Cyclophosphamide (PTCy)-Based Regimen for Graft-Versus-Host Disease Prophylaxis
Authors: Yannan Jia, Xinxin Xia, Jun Yang, Yu Cai, Yin Tong, Chongmei Huang, Huiying Qiu, Kun Zhou, Ying Zhang, Chang Shen, Liping Wan, Xianmin Song
Journal: Blood (2024)
Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Authors: Sharmilan Thanendrarajan, Phil Farmer, Clyde Bailey, Carolina Schinke, Samer Al Hadidi, Maurizio Zangari, Stephanie Rogers, Anne Williams, Fenghuang Zhan, John D Shaughnessy, Jr, Tanvi H. Patel, Anup Kumar Trikannad, Asis Shrestha, Syed Naqvi, Hira Imad Cheema, Trilok Shrivastava, Manozna Karri, Ramya Bachu, Frits van Rhee
Journal: Blood (2024)
Pre-Infusion Ferritin: A Predictive Biomarker for CAR T-Cell Therapy Response in Multiple Myeloma
Authors: Eider Moreno, Mariano Arribas, David A. Martinez, Juana Figueroa Aguirre, Rohan S Patel, Udit Yadav, Erin J Wiedmeier-Nutor, Leif Bergsagel, Rafael Fonseca, Saurabh Chhabra, Januario E. Castro
Journal: Blood (2024)
Retrospective Analysis of Spanish Real-World Data Investigating First Line Treatment Patterns in a Representative Sample of Chronic Lymphocytic Leukemia Patients
Authors: Zuzana Dostalova, Kai Strobel, Tycho Baumann, Fatima Miras, Joaquín Martínez-Lopez, José Antonio Garcia Vela, Stefan Schilling, Markus Rückert
Journal: Blood (2024)
Concomitant Use of Antibiotics During Immune Checkpoint Inhibitor (CPI)-Based Salvage Therapy Does Not Impact Post-ASCT Outcomes in Patients with Relapsed/Refractory Hodgkin Lymphoma (RRHL)
Authors: Gaurav Varma, Maya C. Rosenberg, Erica C. Agbadiba, Austin H. Yeung, Ayo S. Falade, Marcus P. Watkins, Grace T. Baek, Herman van Besien, Kelsey Baron, Meghana K. Subramanian, Sara Prischak, Joe D. Lukowski, Christopher D'Angelo, Jakub Svoboda, Joanna M. Rhodes, Harsh R. Shah, Samuel Yamshon, Ajay K. Gopal, Nancy L. Bartlett, Reid W. Merryman, Ranjana H. Advani, Sairah Ahmed, Catherine S. Diefenbach
Journal: Blood (2024)
Phase 1 Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients with CD7+ T-Cell Non-Hodgkin Lymphoma
Authors: Michael H. Kramer, Neha Mehta-Shah, Michael P. Rettig, Katherine Stricker, Melinda Harding, Feng Gao, Brett Ramsey, Peter Westervelt, Jan K Davidson-Moncada, Armin Ghobadi, John F. DiPersio, Geoffrey L. Uy
Journal: Blood (2024)
Phase 2 Study of Pegylated Interferon in Patients with Essential Thrombocytopenia and Polycythemia Vera: Final Analysis Focused on the Two Diseases
Authors: Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, Gautam Borthakur, Srdan Verstovsek, C. Cameron Yin, Keyur P. Patel, Hagop M. Kantarjian
Journal: Blood (2024)
Safety and Efficacy of Rocbrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma
Authors: Yuqin Song, Qingqing Cai, Keshu Zhou, Ming Jiang, Zhengming Jin, Lei Zhang, Xiuhua Sun, Haiyan Yang, Lanfang Li, Kaiyang Ding, Junyuan Qi, Hongmei Jing, Wei Yang, Min Zhou, Jun Ma, Zhigang Peng, Wei Xu, Hui Zhou, Li Yu, Yuankai Shi, Guohui Cui, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood (2024)
An Artificial Intelligence-Based Federated Learning Platform to Boost Precision Medicine in Rare Hematological Diseases: An Initiative By GenoMed4all and Synthema Consortia
Authors: Gianluca Asti, Saverio D'Amico, Luciana Carota, Davide Piscia, Francesco Casadei, Nono Saha Cyrille Merleau, Patricia Alonso de Apellániz, Anne Sophie Kubasch, Silke Gloaguen, Nicole Modler, Catalina Gonzalez Martin, Cesare Rollo, Juan Parras, Mattia Delleani, Elena Zazzetti, Elisabetta Sauta, Nico Curti, Nicolas Riccardo Derus, Gianluca Carlini, Daniele Dall'Olio, Claudia Sala, Lorenzo Dall'Olio, Luca Lanino, Giulia Maggioni, Alessia Campagna, Marilena Bicchieri, Arturo Bonometti, Cesare Lancellotti, Daoud Rahal, Luca Di Tommaso, Tiziana Sanavia, Piero Fariselli, Matteo Zampini, Matteo Brindisi, Victor Savevski, Uwe Platzbecker, Maria Diez-Campelo, Lin Pierre Zhao, Pierre Fenaux, Torsten Haferlach, Vincent Planat, Raffaella Colombatti, Maria del Mar Mañú-Pereira, Anders Krogh, Silvia Uribe, Santiago Zazo, Enrico Giampieri, Gastone Castellani, Matteo Giovanni Della Porta, Federico Alvarez
Journal: Blood (2024)